Gri Bio, INC. (GRI) — S-1 Filings
All S-1 filings from Gri Bio, INC.. Browse 3 IPO Filing reports with AI-powered summaries and risk analysis.
S-1 Filings (3)
-
GRI Bio Launches Equity Offering to Fund IPF Drug Development
— Dec 8, 2025 Risk: high
GRI Bio, Inc. (GRI) is undertaking a public offering of up to 5,128,205 shares of common stock and accompanying Series F warrants, with an assumed combined publ -
GRI Bio, Inc. Files S-1 for Securities Registration
— Mar 25, 2025 Risk: medium
GRI Bio, Inc. filed an S-1 form on March 25, 2025, to register its securities. The company, formerly known as Vallon Pharmaceuticals, Inc. until April 24, 2023, -
GRI BIO, Inc. Files S-1 for Security Registration
— Jun 20, 2024 Risk: medium
GRI BIO, Inc. (formerly Vallon Pharmaceuticals, Inc.) filed an S-1 form on June 20, 2024, to register securities. The company, incorporated in Delaware with its
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX